Daskal Ilan
CIK 0001446964
EVP, Chief Financial OfficerDirector
Filings
13
Latest Dec 3, 2025
Issuers covered
3
Showing
13 of 13
Page 1
Track record
4 of 4 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 4 | 0% | -5.0% | -3.4% | -3.4% | -10.1% |
| 90 days | 4 | 0% | -81.9% | -101.3% | -23.7% | -101.3% |
| 180 days | 4 | 0% | -146.6% | -165.6% | -89.6% | -165.6% |
| 365 days | 1 | 0% | -472.8% | -472.8% | -472.8% | -472.8% |
Issuers
Companies where Daskal Ilan has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| VIAV | Viavi Solutions Inc. | 9 | Dec 3, 2025 |
| BIO BIOB | Bio-Rad Laboratories, Inc. | 3 | Sep 6, 2023 |
| NTUS | Natus Medical Inc | 1 | Jun 17, 2022 |
All filings
13 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|